SEROEPIDEMIOLOGY AND RISK FACTORS OF HUMAN TOXOPLASMOSIS IN ERBIL, KURDISTAN REGION, IRAQ
Global Journal of Public Health Medicine · 2023
DOI: 10.37557//gjphm.v5i2.209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Public Health Medicine, 2023.
Abstract (Originalsprache)
Introduction
This study aimed at the detection of anti-Toxoplasma. gondii antibodies in human blood samples using immunological tests and to investigate the potential risk factors.
Methods
Five hundred and twenty samples were collected from individuals aged between 10 to 71 years old. All samples were tested by latex, lateral flow assay, and Enzyme-linked immunosorbent assay (ELISA). Personal data which may be potential risk factors were collected.
Results
Out of the 520 Blood samples tested, 23.3%, 25.4%, 20.2%, and 9.8% had positive results for latex, lateral flow assay, ELISA IgG, and ELISA IgM, respectively. The prevalence of T. gondii antibody was high in the elderly age group that had a seropositive result of 26.1%,27.5%, and 23.2% for latex, lateral flow assay, and ELISA IgG, respectively. Conclusion:The two major risk factors associated with the infection are contact with raw meats and consumption of raw vegetables.Latex and lateral flow assay for diagnosis of T. gondii in routine screening might be a cost-effective testing strategy. Consumers are recommended to heat the food of animal origin, and wash all vegetables and fruit carefully before consumption.
Zitieren
APA
(2023). SEROEPIDEMIOLOGY AND RISK FACTORS OF HUMAN TOXOPLASMOSIS IN ERBIL, KURDISTAN REGION, IRAQ. Global Journal of Public Health Medicine. https://doi.org/10.37557//gjphm.v5i2.209
Vancouver
SEROEPIDEMIOLOGY AND RISK FACTORS OF HUMAN TOXOPLASMOSIS IN ERBIL, KURDISTAN REGION, IRAQ. Global Journal of Public Health Medicine. 2023. doi:10.37557//gjphm.v5i2.209
BibTeX
@article{euvimed2023,
title = {SEROEPIDEMIOLOGY AND RISK FACTORS OF HUMAN TOXOPLASMOSIS IN ERBIL, KURDISTAN REGION, IRAQ},
journal = {Global Journal of Public Health Medicine},
year = {2023},
doi = {10.37557//gjphm.v5i2.209}
}
EUVIMED